UNTITLED LETTER
QuVa Pharma, Inc.QuVa Pharma, Inc. – FDA Untitled Letter, Sep 24, 2024
Record Details
This UNTITLED LETTER record concerns QuVa Pharma, Inc., with an inspection on September 24, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 9807dbff-8897-48ee-bc96-bc877d478daf
Violation Codes9
21 U.S.C. 353b21 U.S.C. 360eee-121 U.S.C. 355(a)21 U.S.C. 352(f)(1)21 U.S.C. 331(k)21 U.S.C. 351(a)(2)(B)21 U.S.C. 331(a)21 U.S.C. 351(a)(2)(A)21 CFR 211.192
Full citation text and observation details available on the Dashboard.
Other documents for QuVa Pharma, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.